Medicare Enrolled

Dr. Aliuska Alvarez, MD

Neurology · Miami, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
8370 W FLAGLER ST # 125A, Miami, FL 33144
3052620928
In practice since 2005 (20 years)
NPI: 1801878723 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Alvarez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alvarez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Alvarez

Dr. Aliuska Alvarez is a neurology in Miami, FL, with 20 years in practice. Based on federal Medicare data, Dr. Alvarez performed 467 Medicare services across 317 unique beneficiaries.

Between the years covered by Open Payments, Dr. Alvarez received a total of $38,049 from 63 pharmaceutical and/or device companies across 1052 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Alvarez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ 467 Medicare services$ $38,049 industry payments

Medicare Practice Summary

Medicare Utilization ↗
467
Medicare services
Bottom 48% in FL for neurology
317
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~23 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)181$73$120
Office visit, established patient (30-39 min)177$107$140
New patient office visit (45-59 min)55$140$220
Needle measurement of electrical activity in arm or leg muscles, complete study37$80$150
Office visit, established patient (10-19 min)17$48$80
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$38,049
Total received (2018-2024)
Avg $5,436/year across 7 years
Top 10% in FL for neurology
63
Companies
1,052
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,162 (55.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16,888 (44.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$5,096
2023
$4,272
2022
$3,742
2021
$3,995
2020
$5,413
2019
$15,221
2018
$310

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amneal Pharmaceuticals LLC
$17,205
UCB, Inc.
$2,739
Neurocrine Biosciences, Inc.
$1,699
Teva Pharmaceuticals USA, Inc.
$1,554
ABBVIE INC.
$1,104
AbbVie Inc.
$995
Adamas Pharmaceuticals, Inc.
$869
Eisai Inc.
$840
Neurelis, Inc.
$675
Lundbeck LLC
$650
Biohaven Pharmaceuticals, Inc.
$568
ACADIA Pharmaceuticals Inc
$551
SK Life Science, Inc.
$518
Kyowa Kirin, Inc.
$469
Biogen, Inc.
$408
Otsuka America Pharmaceutical, Inc.
$380
Avanir Pharmaceuticals, Inc.
$371
Biohaven Pharmaceutical Holding Company Ltd.
$360
PFIZER INC.
$349
Takeda Pharmaceuticals U.S.A., Inc.
$318
Lilly USA, LLC
$296
IMPEL PHARMACEUTICALS INC.
$292
ARGENX US, INC.
$283
Allergan, Inc.
$282
Sumitomo Pharma America, Inc.
$280
Alexion Pharmaceuticals, Inc.
$257
Corium, LLC
$234
GENZYME CORPORATION
$229
CATALYST PHARMACEUTICALS, INC.
$224
GE HEALTHCARE
$206
GE HealthCare
$199
Amgen Inc.
$185
Abbott Laboratories
$175
EISAI INC.
$159
Supernus Pharmaceuticals, Inc.
$151
Novartis Pharmaceuticals Corporation
$150
Almatica Pharma LLC
$127
AstraZeneca Pharmaceuticals LP
$125
MDD US Operations, LLC
$121
Sunovion Pharmaceuticals Inc.
$120
SCILEX PHARMACEUTICALS INC.
$113
SANOFI-AVENTIS U.S. LLC
$111
Scilex Pharmaceuticals Inc.
$95
Catalyst Pharmaceuticals, Inc.
$90
Upsher-Smith Laboratories LLC
$88
UPSHER-SMITH LABORATORIES LLC
$82
US WorldMeds, LLC
$80
Vertical Pharmaceuticals, LLC
$72
Azurity Pharmaceuticals, Inc.
$69
Bausch Health US, LLC
$64
IDORSIA PHARMACEUTICALS US INC
$63
BANNER LIFE SCIENCES, LLC
$62
Acorda Therapeutics, Inc
$62
Aprecia Pharmaceuticals, LLC
$49
Merz Pharmaceuticals, LLC
$49
ANI Pharmaceuticals, Inc.
$35
Allergan Inc.
$30
ARBOR PHARMACEUTICALS, INC.
$26
MITSUBISHI TANABE PHARMA AMERICA, INC.
$26
Avion Pharmaceuticals
$22
AbbVie, Inc.
$18
Currax Pharmaceuticals LLC
$14
ASSERTIO THERAPEUTICS, Inc.
$12
Top 3 companies account for 56.9% of total payments
Associated products mentioned in payments ›
ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Apokyn · Austedo XR · BAFIERTAM · BOTOX · Briviact · COMIRNATY · CONTRAVE · Cambia · DIVIGEL · DUOPA · DaTscan · Dhivy · Duopa · EMGALITY · Edarbyclor · FARXIGA · FYCOMPA · Fycompa · GOCOVRI · GRALISE · HORIZANT · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KISUNLA · LORZONE · LYRICA · Leqembi · MIGRANAL · NAPRELAN · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · OSMOLEX ER · OXTELLAR XR · Ongentys · PAXLOVID · PURIFIED CORTROPHIN GEL · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · RADICAVA · REXULTI · RYTARY · Rystiggo · SOLIRIS · Soliris · Spritam · TOPIRAMATE Extended Release Capsules · TOSYMRA · TOUJEO · TRINTELLIX · TROKENDI XR · Trintellix · Trudhesa · UBRELVY · VALTOCO · VIIBRYD · VRAYLAR · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · Vyvanse · XCOPRI · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZTLido · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (56%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for neurology in FL.

Equivalent to $8,148 per 100 Medicare services performed
Looking for a neurology in Miami?
Compare neurologys in the Miami area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
280
Per 100K population
10.4
County median income
$68,694
Nearest hospital
KERALTY HOSPITAL
1.8 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Alvarez is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 10%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Alvarez experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Alvarez performed 181 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alvarez receive payments from pharmaceutical companies?
Yes. Dr. Alvarez received a total of $38,049 from 63 companies across 1,052 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alvarez's costs compare to other neurologys in Miami?
Dr. Alvarez's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alvarez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →